DexCom Current Ratio 2010-2025 | DXCM
Current and historical current ratio for DexCom (DXCM) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. DexCom current ratio for the three months ending June 30, 2025 was 1.52.
| DexCom Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-06-30 | $5.03B | $3.31B | 1.52 |
| 2025-03-31 | $4.55B | $3.04B | 1.50 |
| 2024-12-31 | $4.30B | $2.93B | 1.47 |
| 2024-09-30 | $4.26B | $1.74B | 2.46 |
| 2024-06-30 | $4.85B | $1.72B | 2.82 |
| 2024-03-31 | $4.62B | $1.59B | 2.90 |
| 2023-12-31 | $4.43B | $1.56B | 2.84 |
| 2023-09-30 | $4.70B | $1.68B | 2.80 |
| 2023-06-30 | $5.00B | $2.07B | 2.42 |
| 2023-03-31 | $3.77B | $1.87B | 2.02 |
| 2022-12-31 | $3.67B | $1.84B | 2.00 |
| 2022-09-30 | $3.40B | $0.90B | 3.77 |
| 2022-06-30 | $3.81B | $0.81B | 4.72 |
| 2022-03-31 | $3.75B | $0.71B | 5.27 |
| 2021-12-31 | $3.68B | $0.72B | 5.11 |
| 2021-09-30 | $3.66B | $0.74B | 4.98 |
| 2021-06-30 | $3.47B | $0.60B | 5.78 |
| 2021-03-31 | $3.45B | $0.60B | 5.70 |
| 2020-12-31 | $3.43B | $0.61B | 5.58 |
| 2020-09-30 | $3.24B | $0.51B | 6.39 |
| 2020-06-30 | $3.03B | $0.40B | 7.58 |
| 2020-03-31 | $2.00B | $0.34B | 5.82 |
| 2019-12-31 | $1.97B | $0.36B | 5.47 |
| 2019-09-30 | $1.82B | $0.32B | 5.63 |
| 2019-06-30 | $1.74B | $0.29B | 6.05 |
| 2019-03-31 | $1.69B | $0.24B | 7.18 |
| 2018-12-31 | $1.70B | $0.22B | 7.64 |
| 2018-09-30 | $0.91B | $0.19B | 4.71 |
| 2018-06-30 | $0.84B | $0.17B | 4.90 |
| 2018-03-31 | $0.73B | $0.13B | 5.83 |
| 2017-12-31 | $0.75B | $0.14B | 5.36 |
| 2017-09-30 | $0.69B | $0.12B | 5.86 |
| 2017-06-30 | $0.66B | $0.11B | 6.25 |
| 2017-03-31 | $0.33B | $0.17B | 1.93 |
| 2016-12-31 | $0.28B | $0.10B | 2.73 |
| 2016-09-30 | $0.26B | $0.09B | 3.00 |
| 2016-06-30 | $0.24B | $0.07B | 3.26 |
| 2016-03-31 | $0.23B | $0.06B | 3.55 |
| 2015-12-31 | $0.23B | $0.07B | 3.46 |
| 2015-09-30 | $0.20B | $0.06B | 3.46 |
| 2015-06-30 | $0.17B | $0.04B | 3.86 |
| 2015-03-31 | $0.15B | $0.04B | 3.95 |
| 2014-12-31 | $0.15B | $0.04B | 3.59 |
| 2014-09-30 | $0.12B | $0.04B | 3.04 |
| 2014-06-30 | $0.11B | $0.04B | 2.96 |
| 2014-03-31 | $0.09B | $0.03B | 3.15 |
| 2013-12-31 | $0.09B | $0.03B | 2.90 |
| 2013-09-30 | $0.08B | $0.03B | 2.98 |
| 2013-06-30 | $0.07B | $0.02B | 3.52 |
| 2013-03-31 | $0.07B | $0.02B | 4.40 |
| 2012-12-31 | $0.08B | $0.02B | 3.98 |
| 2012-09-30 | $0.08B | $0.02B | 3.70 |
| 2012-06-30 | $0.08B | $0.02B | 4.95 |
| 2012-03-31 | $0.09B | $0.02B | 5.77 |
| 2011-12-31 | $0.11B | $0.02B | 7.11 |
| 2011-09-30 | $0.12B | $0.02B | 7.82 |
| 2011-06-30 | $0.12B | $0.01B | 9.00 |
| 2011-03-31 | $0.05B | $0.01B | 4.69 |
| 2010-12-31 | $0.07B | $0.02B | 4.32 |
| 2010-09-30 | $0.04B | $0.02B | 2.62 |
| 2010-06-30 | $0.05B | $0.02B | 3.25 |
| 2010-03-31 | $0.06B | $0.02B | 3.73 |
| 2009-12-31 | $0.04B | $0.02B | 1.96 |
| 2009-09-30 | $0.04B | $0.02B | 2.47 |
| 2009-06-30 | $0.05B | $0.02B | 3.26 |
| 2009-03-31 | $0.07B | $0.02B | 4.44 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $30.529B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $174.604B | 21.12 |
| Intuitive Surgical (ISRG) | United States | $169.147B | 70.11 |
| IDEXX Laboratories (IDXX) | United States | $52.172B | 54.30 |
| Edwards Lifesciences (EW) | United States | $45.888B | 30.41 |
| Alcon (ALC) | Switzerland | $41.768B | 28.23 |
| IQVIA Holdings (IQV) | United States | $30.615B | 17.30 |
| Mettler-Toledo (MTD) | United States | $25.882B | 30.72 |
| STERIS (STE) | Ireland | $23.797B | 25.33 |
| Waters (WAT) | United States | $16.625B | 22.84 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.421B | 0.00 |
| Hologic (HOLX) | United States | $15.122B | 16.38 |
| Penumbra (PEN) | United States | $9.340B | 68.23 |
| Sysmex ADR (SSMXY) | Japan | $8.668B | 27.54 |
| Globus Medical (GMED) | United States | $8.046B | 18.51 |
| Masimo (MASI) | United States | $8.006B | 26.94 |
| Teleflex (TFX) | United States | $5.124B | 8.27 |
| Glaukos (GKOS) | United States | $4.991B | 0.00 |
| TransMedics (TMDX) | United States | $4.338B | 65.94 |
| Integer Holdings (ITGR) | United States | $3.693B | 18.43 |
| LivaNova (LIVN) | United Kingdom | $2.706B | 15.49 |
| Alphatec Holdings (ATEC) | United States | $2.267B | 0.00 |
| Veracyte (VCYT) | United States | $2.202B | 30.42 |
| PROCEPT BioRobotics (PRCT) | United States | $2.157B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.052B | 24.49 |
| Artivion (AORT) | United States | $2.027B | 102.29 |
| Elekta AB (EKTAY) | Sweden | $1.853B | 16.66 |
| OPKO Health (OPK) | United States | $1.032B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.001B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.993B | 5.69 |
| IRadimed (IRMD) | United States | $0.890B | 43.21 |
| Tandem Diabetes Care (TNDM) | United States | $0.683B | 0.00 |
| SiBone (SIBN) | United States | $0.664B | 0.00 |
| AxoGen (AXGN) | United States | $0.645B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.622B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.522B | 4.20 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.507B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.488B | 8.62 |
| OrthoPediatrics (KIDS) | United States | $0.472B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.404B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.378B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.368B | 87.58 |
| AngioDynamics (ANGO) | United States | $0.343B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.333B | 8.46 |
| Alpha Tau Medical (DRTS) | Israel | $0.302B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.297B | 0.00 |
| NeuroPace (NPCE) | United States | $0.292B | 0.00 |
| RxSight (RXST) | United States | $0.272B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.271B | 18.72 |
| Neuronetics (STIM) | United States | $0.259B | 0.00 |
| 908 Devices (MASS) | United States | $0.231B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.216B | 0.00 |
| CVRx (CVRX) | United States | $0.196B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.192B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
| LENSAR (LNSR) | United States | $0.156B | 0.00 |
| Accuray (ARAY) | United States | $0.153B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.143B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.128B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| InspireMD (NSPR) | United States | $0.108B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.105B | 0.00 |
| Hyperfine (HYPR) | United States | $0.101B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| Spectral AI (MDAI) | United States | $0.060B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.055B | 0.00 |
| Positron (POSC) | United States | $0.055B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.047B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.023B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 12.76 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |